FasL-positive MVs can theoretically enhance the immune suppression and apoptosis of activated immune cells, and MVs can maintain a relatively high level in the serum of OSCC patients, where they may act as an indicator of the tumor stage [117,118]. Here, FASLG is linked to neoplasm.